| Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells G Napolitani, A Rinaldi, F Bertoni, F Sallusto, A Lanzavecchia Nature immunology 6 (8), 769-776, 2005 | 1388 | 2005 |
| Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma M Compagno, WK Lim, A Grunn, SV Nandula, M Brahmachary, Q Shen, ... Nature 459 (7247), 717-721, 2009 | 1294 | 2009 |
| Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation G Fabbri, S Rasi, D Rossi, V Trifonov, H Khiabanian, J Ma, A Grunn, ... Journal of Experimental Medicine 208 (7), 1389-1401, 2011 | 790 | 2011 |
| Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ... Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013 | 608 | 2013 |
| Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas E Zucca, E Roggero, F Bertoni, F Cavalli Annals of oncology 8 (8), 727-737, 1997 | 550 | 1997 |
| Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ... Blood, The Journal of the American Society of Hematology 118 (26), 6904-6908, 2011 | 494 | 2011 |
| Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ... Cancer cell 27 (4), 516-532, 2015 | 445 | 2015 |
| The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation D Rossi, V Spina, C Deambrogi, S Rasi, L Laurenti, K Stamatopoulos, ... Blood, The Journal of the American Society of Hematology 117 (12), 3391-3401, 2011 | 430 | 2011 |
| BET proteins as targets for anticancer treatment A Stathis, F Bertoni Cancer discovery 8 (1), 24-36, 2018 | 428 | 2018 |
| The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development D Rossi, V Trifonov, M Fangazio, A Bruscaggin, S Rasi, V Spina, S Monti, ... Journal of Experimental Medicine 209 (9), 1537-1551, 2012 | 427 | 2012 |
| Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ... Blood, The Journal of the American Society of Hematology 119 (12), 2854-2862, 2012 | 397 | 2012 |
| The gastric marginal zone B-cell lymphoma of MALT type E Zucca, F Bertoni, E Roggero, F Cavalli Blood, The Journal of the American Society of Hematology 96 (2), 410-419, 2000 | 368 | 2000 |
| The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs M Boi, E Gaudio, P Bonetti, I Kwee, E Bernasconi, C Tarantelli, A Rinaldi, ... Clinical Cancer Research 21 (7), 1628-1638, 2015 | 314 | 2015 |
| Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy G Martinelli, D Laszlo, AJM Ferreri, G Pruneri, M Ponzoni, A Conconi, ... Journal of Clinical Oncology 23 (9), 1979-1983, 2005 | 312 | 2005 |
| Molecular analysis of the progression from Helicobacter pylori–associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach E Zucca, F Bertoni, E Roggero, G Bosshard, G Cazzaniga, E Pedrinis, ... New England Journal of Medicine 338 (12), 804-810, 1998 | 298 | 1998 |
| Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome E Chigrinova, A Rinaldi, I Kwee, D Rossi, PMV Rancoita, JC Strefford, ... Blood, The Journal of the American Society of Hematology 122 (15), 2673-2682, 2013 | 287 | 2013 |
| The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance E Zucca, F Bertoni Blood, The Journal of the American Society of Hematology 127 (17), 2082-2092, 2016 | 285 | 2016 |
| Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ... Blood, The Journal of the American Society of Hematology 131 (22), 2413-2425, 2018 | 279 | 2018 |
| The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas U Novak, A Rinaldi, I Kwee, SV Nandula, PMV Rancoita, M Compagno, ... Blood, The Journal of the American Society of Hematology 113 (20), 4918-4921, 2009 | 279 | 2009 |
| Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma A Rinaldi, I Kwee, M Taborelli, C Largo, S Uccella, V Martin, G Poretti, ... British journal of haematology 132 (3), 303-316, 2006 | 269 | 2006 |
